SUSY Searches at ATLAS

Recent results of searches for supersymmetry by the ATLAS collaboration in up to 2 fb-1 of sqrt(s) = 7 TeV pp collisions at the LHC are reported.Comment: Presented at the 2011 Hadron Collider Physics symposium (HCP-2011), Paris, France, November 14-18 2011, 6 pages, 12 figure

Challenges for early discovery in ATLAS and CMS

The challenges for a discovery of new physics with 1 fb^-1 of LHC data for ATLAS and CMS are discussed. Four specific examples are chosen: a deviation of QCD jet distributions at high E_T, high-mass dilepton pairs, Higgs search in the WW decay channel, and low mass supersymmetry.Comment: 6 pages, 17 figure

Colour Reconnection in W Decays

The studies of colour reconnection in e+e- -> WW -> 4 jets events at LEP are reviewed. It is shown that the analysis of the particle- and energy flow between jets is sensitive to realistic model predictions. The effects on the W mass measurement are discussed.Comment: LaTeX, 6 pages, 3 postscript figure

Supersymmetry searches at the LHC

Recent results in the search for supersymmetry in pp collisions at sqrt(s) = 7 TeV and sqrt(s) = 8 TeV by the ATLAS and CMS experiments at the LHC are reviewed. After discussing features of inclusive analyses and the presentation of results, emphasis will be put on searches for the third generation squarks, on searches for gauginos, and on possible ways supersymmetry could escape the present analyses.Comment: 14 pages, 9 figures. Proceedings of Physics in Collision 201

Prospects for SUSY searches in CMS and ATLAS

We discuss how the CMS and ATLAS experiments are preparing for the analysis of first LHC data with emphasis on the search for supersymmetry. We will show the importance of the understanding of detector, trigger, reconstruction and backgrounds, and we will present realistic estimates of the reach of CMS and ATLAS.Comment: 9 pages, 12 figures. Contribution to the proceedings of the 16th international conference on supersymmetry and the unification of fundamental interactions, SUSY08, Seoul, Korea, June 16-21, 200

From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria

From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria. Many subjects nowadays present with end-stage renal failure and its attendant cardiovascular complications without known prior renal damage. In this report we review the evidence available to strongly suggest that the present practice of secondary prevention in those with known prior renal disease should be extended to primary prevention for those subjects in the general population who are at risk for progressive renal failure, but who had never suffered from a primary renal disease. We show that such subjects can be detected by screening for albuminuria. Elevated urinary albumin loss is an indicator not only of poor renal, but also of poor cardiovascular prognosis. In addition to diabetic subjects who are at risk for albuminuria, we also show that hypertensive, obese, and smoking subjects are more susceptible. We suggest that therapies that have been shown to lower albumin excretion, such as ACE inhibitors, angiotensin II receptor antagonists, and statins be started early in such patients to prevent them from developing clinical renal disease and its attendant cardiovascular complications

European White Book on Real-Time Power Hardware in the Loop Testing : DERlab Report No. R- 005.0

The European White Book on Real-Time-Powerhardware-in-the-Loop testing is intended to serve as a reference document on the future of testing of electrical power equipment, with specifi c focus on the emerging hardware-in-the-loop activities and application thereof within testing facilities and procedures. It will provide an outlook of how this powerful tool can be utilised to support the development, testing and validation of specifi cally DER equipment. It aims to report on international experience gained thus far and provides case studies on developments and specifi c technical issues, such as the hardware/software interface. This white book compliments the already existing series of DERlab European white books, covering topics such as grid-inverters and grid-connected storag

Eosinophilic cystitis

We describe four cases of eosinophilic cystitis in whom no specific cause could be found, and review the literature. Complaints at presentation included urgency, frequency, abdominal pain, and haematuria. In three patients the symptoms and ultrasound pictures suggested a bladder tumour. One patient was treated with anticholinergics and corticosteroids without relief of symptoms; a localised eosinophilic tumour was excised in one patient who remained symptom free; and two patients were managed conservatively with spontaneous resolution of bladder pathology and symptoms. One case was identified by random bladder biopsy in 150 consecutive patients with unexplained irritable micturition complaints. Eosinophilic cystitis is rare in children. After biopsy, we consider a wait and see policy is justified as symptoms tend to disappear spontaneously. Routine bladder biopsies in children with unexplained bladder symptoms is not justifiable

Antibiotic drug use of children in the Netherlands from 1999 till 2005

Objective Antibiotics are the most commonly prescribed drugs used by children. Excessive and irrational use of antibiotic drugs is a world-wide concern. We performed a drug utilization study describing the patterns of antibiotic use in children aged 0-19 years between 1999 and 2005 in the Netherlands. Methods We used IADB.nl, a database with pharmacy drug dispensing data covering a population of 500,000 people and investigated all prescriptions of oral antibiotic drugs (ATC J01) for children Results The total number of antibiotic prescriptions per 1000 children per year ranged from 282 in 2004 to 307 in 2001 and did not change between years during the study period in a clinically relevant way. The prevalence of receiving at least one prescription varied between 17.8% in 2004 and 19.3% in 2001. Amoxicillin was the most frequently prescribed drug (46.4% of all antibiotic prescriptions in 1999 and 43.2% in 2005). Between 1999 and 2005 there was a shift from the small-spectrum phenethicillin, a penicillin preparation [ratio 2005/1999 0.76; 95% confidence interval (CI) 0.72-0.81], to amoxicillin/clavulanic acid (ratio 2005/1999 1.70; 95% CI 1.61-1.79) and from the old macrolide erythromycin (ratio 2005/1999 0.35; 95% CI 0.32-0.39) to the new macrolide antibiotic azithromycin (ratio 2005/1999 1.78; 95% CI 1.65-1.92). Conclusion The use of antibiotic drugs in treating children in the Netherlands is comparable to that in other northern European countries. Broad-spectrum antibiotics were prescribed more frequently than recommended by the guidelines and increased during our study period. Initiatives to improve guideline-directed antibiotic prescribing are strongly recommended